Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Sandy Spring Bank

Sandy Spring Bank boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,634 shares of the medical equipment provider’s stock after purchasing an additional 683 shares during the quarter. Sandy Spring Bank’s holdings in Intuitive Surgical were worth $7,116,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Howard Capital Management Group LLC boosted its position in Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. boosted its position in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after purchasing an additional 9,194 shares during the period. Quest Partners LLC acquired a new position in Intuitive Surgical during the 3rd quarter valued at approximately $173,000. Pathstone Holdings LLC boosted its position in Intuitive Surgical by 2.6% during the 3rd quarter. Pathstone Holdings LLC now owns 48,928 shares of the medical equipment provider’s stock worth $24,037,000 after acquiring an additional 1,228 shares during the period. Finally, Banque Cantonale Vaudoise boosted its position in Intuitive Surgical by 6.1% during the 3rd quarter. Banque Cantonale Vaudoise now owns 8,332 shares of the medical equipment provider’s stock worth $4,094,000 after acquiring an additional 480 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.7 %

NASDAQ:ISRG opened at $492.06 on Thursday. The firm has a market capitalization of $175.26 billion, a price-to-earnings ratio of 76.76, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business’s fifty day moving average price is $564.39 and its 200 day moving average price is $531.62.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Barclays boosted their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.